April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Patrick Forde: Big News in Small Cell Lung Cancer: Tarlatamab Improves Survival vs. 2nd Line Chemo
Apr 12, 2025, 03:13

Patrick Forde: Big News in Small Cell Lung Cancer: Tarlatamab Improves Survival vs. 2nd Line Chemo

Patrick Forde, Professor at The Johns Hopkins University, shared a post on X:

“Big news in small cell lung cancer, a disease which historically has had a very poor prognosis. The T cell engager, tarlatamab improves survival vs. 2nd line chemo. Hope is that durable responses will be seen and early phase data were encouraging.”

First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy